Follistatin-344
Active Substance: Follistatin-344
Description
Follistatin-344, also known as FS-344, is a synthetic, full-sized version of the naturally occurring glycoprotein Follistatin (FST). Its primary function is to act as an antagonist for several proteins in the transforming growth factor-β (TGF-β) superfamily, particularly myostatin and activin. Myostatin is a protein that naturally limits muscle growth. By inhibiting myostatin, Follistatin-344 promotes muscle hypertrophy (increase in muscle cell size) and hyperplasia (increase in the number of muscle cells). This makes it a subject of research for treating conditions like muscular dystrophy and for potential use in muscle enhancement.
Benefits and Side Effects
Benefits
-
Significant Muscle Growth: By inhibiting myostatin, FS-344 allows for uninhibited muscle development, leading to notable increases in muscle mass and strength.
-
Enhanced Strength: The increase in muscle mass directly translates to improved physical strength.
-
Faster Recovery: It can accelerate the repair of muscle tissue after exercise, reducing recovery time.
-
Potential Fat Loss: The increase in lean muscle mass can raise the body's metabolic rate, which may contribute to a reduction in body fat.
-
Hair Growth: Some studies have suggested it may increase hair follicle growth and thickness.
Side Effects
-
Limited Research: Most information on side effects comes from animal studies and anecdotal reports, not from human clinical trials.
-
Increased LDL Cholesterol: In some individuals, a slight increase in LDL (bad) cholesterol has been observed.
-
Cardiovascular Risks: Given the limited research, long-term effects on the heart and other organs are unknown.
-
Reproductive Effects: Since follistatin is involved in reproductive health by suppressing follicle-stimulating hormone (FSH), there are concerns about its potential impact on the hypothalamic-pituitary-gonadal axis, though some studies suggest that the specific FS-344 isoform may not have these off-target effects.
Pros and Cons
Pros
-
Potent Anabolic Effects: It's a very powerful myostatin inhibitor, leading to significant muscle growth.
-
Non-Androgenic: Unlike anabolic steroids, it doesn't affect androgen levels, so it avoids side effects like hair loss, acne, and prostate enlargement.
-
Gene Therapy Potential: Follistatin is a candidate for gene therapy to treat muscle-wasting diseases, with some therapies showing effects lasting up to a year.
Cons
-
Safety Concerns: It is not approved for human use and is considered an experimental research chemical. The long-term safety profile is unknown.
-
Lack of Regulation: It is primarily available on the black market, and product quality, purity, and concentration are not guaranteed.
-
High Cost: Gene therapies and pure research-grade peptides can be extremely expensive.
-
No Established Protocols: There are no officially sanctioned guidelines for its use, including dosage, frequency, and administration method.
Dosage and Frequency
There is no standardized or medically approved dosage for Follistatin-344 as it is not a regulated medication. Any dosages mentioned are purely speculative and based on anecdotal use within research or bodybuilding communities. A common suggested regimen is a dose of 100-200 mcg per day for a period of 1-2 weeks, followed by a break. It's often administered via subcutaneous injection. However, such information is for educational purposes only and should not be used as a guide for self-administration.
Half-Life and Detection Time
The half-life of Follistatin-344 is not definitively established in humans, but studies on a similar mRNA-based delivery system in mice showed elevated levels for up to 72 hours post-injection, with levels returning to baseline within 4 days. The detection time for Follistatin-344, particularly in a doping context, can be difficult to determine due to its similarity to the naturally occurring protein. However, some black market versions may contain a His-tag, a small protein modification that allows it to be distinguished from endogenous follistatin. This could make it detectable in drug tests, but the exact detection window is not widely publicized.
Sterogenic, Progestogenic, and Prolactin Effects
-
Sterogenic/Androgenic: Follistatin-344 is not sterogenic. It does not bind to androgen receptors or affect testosterone levels. Therefore, it does not have anabolic androgenic properties.
-
Progestogenic: There is no evidence to suggest that Follistatin-344 has progestogenic effects.
-
Prolactin: Research suggests that Follistatin does not have a direct role in prolactin expression or production. While it can interact with other hormones, its effect on prolactin seems to be negligible.
Anabolic Androgenic Ratio
The anabolic-androgenic ratio is a classification used for anabolic steroids to compare their anabolic (muscle-building) and androgenic (masculinizing) effects. Since Follistatin-344 is not a steroid and does not have androgenic properties, it does not have a measurable anabolic-androgenic ratio. Its anabolic effects are mediated by a completely different mechanism—the inhibition of myostatin—rather than through the androgen receptor.
Pharmacological Properties
Half Life
1.5 days
Active Dose
100%
Detection
7.50 days
Concentration
5000 mcg/vial
Anabolic/Androgenic Profile
Usage Effectiveness
Activity Profile
Estrogenic
None
Progestanic
None
Water Retention
None
Aromatization
No
Benefits
Dosage Recommendations
Beginner
100-200 mcg/week
Intermediate
200-300 mcg/week
Advanced
300-500 mcg/week
Evidence-based planning resources
Dive deeper into Follistatin-344 cycle design, stacking options, and harm-reduction checklists available inside Anabolic Planner.
- Follistatin-344 compound database overviewCompare Follistatin-344 with other peptide agents in the structured compound index.
- Follistatin-344 stack and cycle templatesReview evidence-based cycle outlines, dose progressions, and PCT pairings that incorporate Follistatin-344.
- Harm-reduction guide for Follistatin-344Refresh safety monitoring, lab work, and countermeasure strategies tailored for Follistatin-344 protocols.
Peer-reviewed reference material
Validate mechanisms, contraindications, and regulatory guidance for Follistatin-344 with trusted clinical databases.
- Follistatin-344 clinical research on PubMedSearch peer-reviewed human and veterinary studies discussing efficacy, endocrine impact, and contraindications.
- Follistatin-344 pharmacology via Drug Information PortalReview mechanisms, synonyms, regulatory status, and toxicology summaries from the U.S. National Library of Medicine.
Side Effects
Rare
Severe
Safety Information
Liver Toxicity
None
Kidney Toxicity
Low
Cardiovascular Risk
Low
Disclaimer: This information is for educational purposes only. Always consult with a qualified healthcare professional before using any compounds.